Keywords: بتا آگونیست کوتاه مدت; Asthma control; Children; Asthma; Health resource utilization; Expenditures; AC; All-cause; ACQ; Asthma Control Questionnaire; AS; Asthma-specific; ED; Emergency department; HC; Household Component; HRU; Health resource utilization; ICD-9; International C
مقالات ISI بتا آگونیست کوتاه مدت (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: بتا آگونیست کوتاه مدت; Pediatric; Summer camp; Allergy; Anaphylaxis; Asthma; Epinephrine autoinjector; Urgent care; Emergency care; EHR; Electronic health record; ICS; Inhaled corticosteroid; LABA; Long-acting β-agonist; NHANES; National Health and Nutrition Examination Survey
Keywords: بتا آگونیست کوتاه مدت; Asthma; Telemedicine; SABA monitoring; Propeller Health; ACT; Asthma Control Test; MMG; Mercy Medical Group; NAEPP; National Asthma Education and Prevention Program; RC; Routine care; SABA; Short-acting β-agonist; WHC; Woodland Healthcare;
Keywords: بتا آگونیست کوتاه مدت; asthma; eosinophil; phase 3; reslizumab; ACQ; Asthma Control Questionnaire; ADA; anti-drug antibody; AE; adverse event; FAS; full analysis set; ICS; inhaled corticosteroid; LABA; long-acting β-agonist; LS; least squares; SABA; short-acting β-agonist;
Keywords: بتا آگونیست کوتاه مدت; Asthma; overweight; obesity; children; dyspnea; breathlessness; shortness of breath; esophageal reflux; ACQ6; 6-Item Asthma Control Questionnaire without the FEV1 component; ACT; Asthma Control Test; ASUI; Asthma Symptom Utility Index; BMI; Body mass inde
Keywords: بتا آگونیست کوتاه مدت; Asthma; Asthma control; Maintenance of asthma control; Asthma Control Test; Asthma follow-up; Asthma exacerbations; ACT; Asthma Control Test; BMI; Body mass index; CI; Confidence interval; ED; Emergency department; SABA; Short-acting β-agonist;
Keywords: بتا آگونیست کوتاه مدت; Lung sound analysis; Airway inflammation; Bronchial asthma; Ach; Acetylcholine; E-I LF; Expiratory-inspiratory ratio of sound power in the low-frequency range; Exp LF; Sound power during expiration; FeNO; Exhaled nitric oxide; FVC; Forced vital capacity;
Keywords: بتا آگونیست کوتاه مدت; Pediatrics; Asthma; Physician training; Inhaled corticosteroids; Spirometry; %FEV1; Percentage predicted FEV1; BMI; Body mass index; CT; Computed tomography; CXR; Chest radiography; ED; Emergency department; FVC; Forced vital capacity; GERD; Gastroesophag
Long-Acting β-Agonist in Combination or Separate Inhaler as Step-Up Therapy for Children with Uncontrolled Asthma Receiving Inhaled Corticosteroids
Keywords: بتا آگونیست کوتاه مدت; Asthma; Child; Inhaled corticosteroid; Long-acting β-agonist; Step-up therapy; aOR; Adjusted odds ratio; aRR; Adjusted rate ratio; BDP; Beclomethasone dipropionate; BTS/SIGN; The British Thoracic Society and Scottish Intercollegiate Guidelines Network; C
Childhood asthma exacerbations and the Arg16 β2-receptor polymorphism: A meta-analysis stratified by treatment
Keywords: بتا آگونیست کوتاه مدت; Adrenergic receptors; asthma; child; disease exacerbation; therapeutics; ADRB2; β2-Adrenoceptor gene; GALA II; Genes-Environments and Admixture in Latino Americans; HWE; Hardy-Weinberg equilibrium; ICS; Inhaled corticosteroid; LABA; Long-acting β-agonis
Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthma
Keywords: بتا آگونیست کوتاه مدت; Asthma; roflumilast; montelukast; phosphodiesterase 4 inhibitors; ACQ; Asthma Control Questionnaire; AE; Adverse event; ANCOVA; Analysis of covariance; ATS; American Thoracic Society; BMI; Body mass index; COPD; Chronic obstructive pulmonary disease; C-SS
Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment
Keywords: بتا آگونیست کوتاه مدت; CRTH2 antagonist; Asthma; Inhaled corticosteroid; ACQ; Asthma Control Questionnaire; AQLQ; Asthma Quality of Life Questionnaire; AUC; area under the curve; bid; twice daily; CI; confidence interval; CRTH2; chemoattractant receptor homologous molecule on T
IL-13 desensitizes β2-adrenergic receptors in human airway epithelial cells through a 15-lipoxygenase/G protein receptor kinase 2 mechanism
Keywords: بتا آگونیست کوتاه مدت; IL-13; cAMP; phosphatidylethanolamine binding protein 1; 15-lipoxygenase 1; β2-adrenergic receptor; G protein receptor kinase 2; asthma; ALI; Air-liquid interface; ALOX15; Arachidonate 15-lipoxygenase; β2AR; β2-Adrenergic receptor; cAMP; Cyclic adenosi
Pharmacogenetics: Implications of race and ethnicity on defining genetic profiles for personalized medicine
Keywords: بتا آگونیست کوتاه مدت; Asthma; genes; pharmacogenetics; response heterogeneity; single nucleotide polymorphism; admixture mapping; ethnic group; ADRB1; β1-Adrenergic receptor; ADRB2; β2-Adrenergic receptor; BADGER; Best Add-on Therapy Giving Effective Response Trial; BARGE; B
The relationship between combination inhaled corticosteroid and long-acting β-agonist use and severe asthma exacerbations in a diverse population
Keywords: بتا آگونیست کوتاه مدت; Long-acting β-agonist; inhaled corticosteroid; severe asthma exacerbation; safety; racially and ethnically diverse population; observational study; FDA; US Food and Drug Administration; HR; Hazard ratio; ICS; Inhaled corticosteroid; LABA; Long-acting β-
Further validation and definition of the psychometric properties of the Asthma Impact Survey
Keywords: بتا آگونیست کوتاه مدت; Asthma; quality of life; Asthma Impact Survey; validation; psychometric properties; ACT; Asthma Control Test; AIS-6; Asthma Impact Survey; ED; Emergency department; ICC; Intraclass correlation coefficient; KPSC; Kaiser Permanente Southern California; mAQL
Phenotypic Expressions of Childhood Wheezing and Asthma: Implications for Therapy
Keywords: بتا آگونیست کوتاه مدت; CAMP; Childhood Asthma Management Program; EPR-3; Expert Panel Report 3; FEV1; Forced expiratory volume in 1 second; ICS; Inhaled corticosteroid; LABA; Long-acting β-agonist; LTRA; Leukotriene receptor antagonist; mAPI; Modified Asthma Predictive Index;
Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence
Keywords: بتا آگونیست کوتاه مدت; Medication adherence; inhaled corticosteroids; asthma; patient compliance; asthma exacerbations; ACT; Asthma Control Test; ED; Emergency department; HR; Hazard ratio; ICS; Inhaled corticosteroid; SABA; Short-acting β-agonist; SAPPHIRE; Study of Asthma Ph
The minimally important difference of the Asthma Control Test
Keywords: بتا آگونیست کوتاه مدت; Asthma; asthma control; Asthma Control Test; minimally important difference; distribution-based method; anchor-based method; ACQ; Asthma Control Questionnaire; ACT; Asthma Control Test; MID; Minimally important difference; SABA; Short-acting β-agonist;
Impact of Asthma Controller Medications on Clinical, Economic, and Patient-Reported Outcomes
Keywords: بتا آگونیست کوتاه مدت; ATAQ; Asthma Therapy Assessment Questionnaire; BMI; body mass index; COPD; chronic obstructive pulmonary disease; ED; emergency department; HIPAA; Health Insurance Portability and Accountability Act; ICD-9-CM; International Classification of Diseases, Nin
Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis
Keywords: بتا آگونیست کوتاه مدت; Prostaglandin D receptor gene promoter; asthma susceptibility; airway disease; montelukast; AE; Adverse experience; AR; Allergic rhinitis; CRTH2; Chemoattractant receptor-homologous molecule on T-helper type 2 cells, also known as DP2; DASS; Daytime Asthm
Formulating an Effective and Efficient Written Asthma Action Plan
Keywords: بتا آگونیست کوتاه مدت; ACT; Asthma Control Test; ED; emergency department; FACET; Formoterol and Corticosteroids Establishing Therapy; ICS; inhaled corticosteroid; LABA; long-acting β-agonist; NAEPP; National Asthma Education and Prevention Program; PEF; peak expiratory flow;
Interactive effects of steroids and β-agonists on accumulation of type 2 T cells
Keywords: بتا آگونیست کوتاه مدت; Human; T cells; β-adrenergic receptor; β-agonist; asthma; IL-13; glucocorticosteroid; steroid; IL-2; β2AR; β2-Adrenergic receptor; GM; Geometric mean; Kd; Dissociation constant; LABA; Long-acting β-agonist; PBL; Peripheral blood lymphocyte; SABA; Sho
Asthma Treatment in a Population-Based Cohort: Putting Step-Up and Step-Down Treatment Changes in Context
Keywords: بتا آگونیست کوتاه مدت; ED; emergency department; ICS; inhaled corticosteroid; LABA; long-acting β-agonist; LM; leukotriene modifier; NAEPP; National Asthma Education and Prevention Program; SABA; short-acting β-agonist;
Short-Acting β-Agonist Prescription Fills as a Marker for Asthma Morbidity
Keywords: بتا آگونیست کوتاه مدت; administrative database; asthma; asthma emergency department visits; asthma hospitalizations; asthma outcomes; β-agonists; CI; confidence interval; ED; emergency department; ICD9-CM; International Classification of Diseases, Ninth Revision, Clinical Modi